Health
Centre Signs PPP With Bharat Biotech For Development Plus Commercial Production Of Intranasal Covid-19 And Malaria Vaccines
Swarajya Staff
Mar 27, 2022, 01:51 PM | Updated 01:51 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
The central government has signed a public-private partnership with Bharat Biotech to develop and commercialise the intranasal Covid-19 and malaria vaccines.
These vaccines will be made by the pharmaceutical company’s unit in Odisha named Sapigen Biologix Private Limited.
Bharat Biotech is looking to establish an advanced facility in Bhubaneswar to manufacture the aforementioned two vaccines.
It will then expand their portfolio of products by adding more vaccines.
The company has set a target of producing 100 million doses of the intranasal Covid-19 vaccine by April 2023. It will also manufacture 15 million doses of the said malaria vaccine by the end of April 2025, Financial Express reports.
The intranasal vaccine generates mucosal immune response and thus protects both the upper and lower respiratory systems of a vaccinated individual.
It is believed to be helpful with respect to breaking the cycle of infection and transmission of the virus.
The two vaccines are novel and will be commercially produced for the very first time.
Meanwhile, Bharat Biotech’s co-founder Dr Krishna Ella has also agreed to direct a fund of Rs 200 crore for the development of sustainable startups in India.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.